In a small randomized trial, people who took capsules containing donated gut microbiomes experienced fewer gastrointestinal symptoms than those taking a placebo.
The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.
